Therefore, it is of interest to use visfatin as a prototype adipokine to study obesity‐associated endothelial injury by exploring whether adipokines can directly cause endothelial cell dysfunction or injury. This evidence concerns the gene NAMPT and obesity due to melanocortin 4 receptor deficiency.